Search

everythinglearnresearchcommunity

for

Search:↓

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

Thioglycolic acid in hair products may pose reproductive and cancer risks for hairdressers.

Practitioners treating hair loss need better education and resources to overcome challenges like commercial bias and ethical dilemmas.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

TGF-β1 and 2 in hair follicles may be linked to hair loss in AGA.

PAD3 plays a key role in hair and skin protein structure and may be linked to skin diseases.

Men with male pattern baldness have higher blood sugar, bad cholesterol, and ZAG protein levels than healthy men.

The document's conclusion cannot be provided because the document is not accessible or understandable.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Low-level light therapy safely improves hair coverage, thickness, and count in androgenetic alopecia patients.

Leydig cells can cause testosterone-secreting adrenal tumors in women.

18β-glycyrrhetinic acid from licorice root is good for skin and hair treatments but has absorption challenges.

Finasteride is effective and safe for treating hair loss, working better in younger men.

Advocacy groups should avoid marketing partnerships that may imply drug endorsements.

Dutasteride 0.5mg is more effective than finasteride 1mg for treating male pattern baldness.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

Laser-assisted drug delivery is generally safe with mostly mild side effects.

AGEs and their receptors play a significant role in hair loss by causing inflammation and oxidative stress.

Wnt/β-catenin and TGF-β pathways affect hair loss, and activating Wnt/β-catenin could be a potential treatment.

DNCB is highly effective for treating alopecia areata with minimal long-term side effects.

Pharmacists play a crucial role in customizing treatments and ensuring medication safety.

Stauntonia hexaphylla extract can help treat hair loss by blocking certain hormones.

A specific gene change in APCDD1 increases the risk of hair loss.

The topical solution increased hair count but wasn't significantly better than placebo in other measures.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Scalp dermatoscopy helps diagnose and monitor hair loss severity.

Minoxidil-dutasteride tattooing can potentially help regrow hair, especially in men who already have some thin hair.

Mini pulse corticosteroid therapy with oral dexamethasone is effective and has fewer side effects for treating extensive alopecia areata.